 | Vol. 8.33 – 25 August, 2020 |
| |
|
|
| Researchers generated human islet-like organoids from induced pluripotent stem cells and showed that non-canonical WNT4 signaling drove the metabolic maturation necessary for robust ex vivo glucose-stimulated insulin secretion. [Nature] |
|  |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| A pan-tissue aryl hydrocarbon receptor (AHR) signature, derived by natural language processing, revealed that across 32 tumor entities, interleukin-4-induced-1 ( IL4I1) associated more frequently with AHR activity than IDO1 or TDO2, hitherto recognized as the main Trp-catabolic enzymes. [Cell] |
|
|
|
| Active T-lymphocytes and decreased macrophages were present at residual disease and immunosuppressive cell states characterized progressive disease. Biological features revealed by scRNA-seq were biomarkers of clinical outcomes in independent cohorts. [Cell] |
|
|
|
| Investigators used mass cytometry to show that two recently defined human neutrophil progenitor populations contained a homogeneous progenitor subset they termed “early neutrophil progenitors”. [Immunity] |
|
|
|
| Scientists report that PD-L1 translocated from the plasma membrane into the nucleus through interactions with components of the endocytosis and nucleocytoplasmic transport pathways, regulated by p300-mediated acetylation and HDAC2-dependent deacetylation of PD-L1. [Nature Cell Biology] |
|
|
|
| Using a human leukocyte antigen–A2–specific CAR platform and human Tregs, the authors compared ten CARs with different co-receptor signaling domains and systematically tested their function and CAR-stimulated gene expression profile. [Science Translational Medicine] |
|
|
|
| Scientists report that maganese was essential in innate immune sensing of tumors and enhanced adaptive immune responses against tumors. [Cell Research] |
|
|
|
| The authors compared the peripheral blood mononuclear cells (PBMC) mitochondrial respiration of 19 hospitalized Stage D heart failure patients with 19 healthy participants. They then created an in vitro model of sterile inflammation by treating healthy PBMC with MitoDAMP isolated from human heart tissue. [Journal of Clinical Investigation] |
|
|
|
| Researchers present an avidity-controlled chimeric antigen receptors (AvidCAR) platform with inducible and logic control functions. [Nature Communications] |
|
|
|
| Investigators analyzed exomes, transcriptomes, and low pass whole genomes from 167 gallbladder cancers from patients in Korea, India and Chile. [Nature Communications] |
|
|
|
| Scientists showed that monocytes engulfed colloidal calciprotein particles via macropinocytosis, and this process was strictly dependent on calcium-sensing receptor signaling triggered by increases in [Ca2+]ex. [Nature Communications] |
|
|
|
| Researchers characterized the ontogeny of skeletal muscle-resident macrophages by lineage tracing and bone marrow transplant experiments. [Proceedings of the National Academy of Sciences of the United States of America] |
|  |
|
|
|
| The authors evaluate the potential benefits to the immune system that arise by taking advantage of some of the brain’s unique features, such as its capacity to integrate and synchronize physiological functions, its predictive capacity and its speed of response. [Nature Reviews Immunology] |
|
|
|
| Scientists discuss molecular identification of different tumor antigen types, and the clinical safety and efficacy of targeting them with immunotherapy. [Cancer Cell] |
|
|
|
| Investigators discuss the current knowledge of the immune response in thyroid cancers, the latest and ongoing immune-based approaches, and the future of immunotherapies in thyroid cancer. [Nature Reviews Endocrinology] |
|
|
|
|
| Primary HLH is a family of devastating primary immune deficiencies with limited treatment options and no gene therapies under clinical testing. Expression Therapeutics has developed a promising and potentially curative gene therapy candidate for familial HLH type 3. [Expression Therapeutics (PR Newswire Association LLC.)] |
|
|
|
| Indee Labs is a biotechnology company developing the µVS Delivery SystemTM for non-viral intracellular or gene delivery. The team at Indee Labs was awarded a grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop the µVS Delivery SystemTM for modified regulatory T cells. [Indee Labs (BusinessWire, Inc.)] |
|
|
|
|
| October 13-16, 2020 Virtual |
|
|
|
|
|
| STEMCELL Technologies – Flexible |
|
|
|
| Princess Margaret Cancer Center – Toronto, Ontario, Canada |
|
|
|
| Roswell Park Center for Immunotherapy – Buffalo, New York, United States |
|
|
|
| Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States |
|
|
|
| The Francis Crick Institute – London, United Kingdom |
|
|
|
|